Swati Jayaram | Medicine | Best Researcher Award

Published on by Global Diseases Research

Best Researcher Award

Swati Jayaram
The Ohio State University

Swati Jayaram
Affiliation The Ohio State University
Country India
Scopus ID 57966951000
Documents 4
Citations 1
h-index 1
Subject Area Medicine
Event Global Diseases Research Awards

The Best Researcher Award recognizes scholarly achievement, research productivity, and meaningful contributions to scientific advancement. Swati Jayaram of The Ohio State University has developed an academic profile within the field of medicine through peer-reviewed publications and participation in scientific research activities. Her documented scholarly record demonstrates engagement with evidence-based investigation and knowledge dissemination within the biomedical sciences.[1]

Abstract

Swati Jayaram is affiliated with The Ohio State University and has contributed to the field of medicine through scholarly publications and academic research activities. Her documented research profile reflects participation in scientific investigations that support evidence-based understanding and clinical knowledge development. Available bibliometric indicators demonstrate a developing publication record with measurable citation activity. The Best Researcher Award recognizes individuals whose academic efforts contribute to scientific communication, research quality, and professional advancement. Based on available scholarly metrics and publication records, her work represents ongoing engagement in medical research and supports broader objectives associated with innovation, scientific inquiry, and academic excellence within healthcare-related disciplines.[1]

Keywords

Medicine, Medical Research, Academic Excellence, Scientific Publications, Healthcare Research, Evidence-Based Medicine, Scholarly Impact, Research Productivity, Best Researcher Award, Global Diseases Research Awards.

Introduction

Academic recognition programs play an important role in highlighting research achievements and encouraging continued scientific advancement. The Best Researcher Award acknowledges individuals who demonstrate commitment to scholarly investigation, publication quality, and professional contributions that strengthen knowledge development across scientific disciplines and healthcare-related research environments.[2]

Research Profile

Swati Jayaram is associated with The Ohio State University and maintains a documented research presence within the medical sciences. Bibliometric information available through Scopus indicates four indexed publications, one citation, and an h-index of one, reflecting an emerging scholarly profile supported by peer-reviewed academic contributions.[1]

Research Contributions

Research contributions associated with Swati Jayaram demonstrate participation in scientific inquiry relevant to medicine and healthcare. Through publication activities and collaboration within academic environments, her work contributes to the dissemination of knowledge, supports evidence-based understanding, and strengthens the broader framework of medical research and scholarly communication.[1]

Publications

The publication record indexed under the Scopus author profile demonstrates engagement with peer-reviewed scholarly dissemination. Publications contribute to academic visibility, facilitate scientific discussion, and provide measurable outputs that support the evaluation of research performance. Such outputs remain important indicators of sustained participation in scholarly activities.[1]

Research Impact

Research impact is commonly assessed through publication metrics, citation performance, and scholarly visibility. Available indicators associated with Swati Jayaram suggest developing influence within the academic literature. Citation activity, although limited in quantity, demonstrates that published work has entered the scientific record and contributed to ongoing scholarly engagement.[1]

Award Suitability

The Best Researcher Award evaluates research productivity, academic commitment, publication quality, and professional contributions. Based on documented scholarly activities, Swati Jayaram demonstrates characteristics aligned with the objectives of academic recognition programs. Her participation in medical research and scientific publication supports consideration within award frameworks focused on research excellence and scholarly achievement.[2]

Conclusion

Swati Jayaram’s academic profile reflects involvement in medical research, peer-reviewed publication, and scholarly communication. Her documented contributions, supported by indexed research outputs and citation activity, demonstrate engagement with scientific advancement. These characteristics align with the principles recognized by the Best Researcher Award and highlight ongoing participation in academic research initiatives.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Swati Jayaram, Author ID 57966951000. Scopus.https://www.scopus.com/authid/detail.uri?authorId=57966951000
  2. Global Diseases Research Awards. (n.d.). Best Researcher Award and recognition framework.https://globaldiseases.org/
  3. Gillespie, M. L., Jayaram, S., Eisner, M., Sliemers, S., Pasley, K., McCoy, K., & Krivchenia, K. (2025). Edinburgh postnatal depression scale score elevation in caregivers of infants with cystic fibrosis. Pediatric Pulmonology, 60(1), e27364. https://doi.org/10.1002/ppul.27364
  4. Jayaram, S., Khuhro, A., Krivchenia, K., & Kalra, M. (2026). Frontal lobe epilepsy presenting as parasomnia in a child on BiPAP for severe obstructive sleep apnea. Sleep, 49(Supplement_1), A597. https://doi.org/10.1093/sleep/zsag091.1339

“`

Gulnara Yuldasheva | Drug Synergy | Women Researcher Award

Published on by Global Diseases Research

Women Researcher Award

Research Profile
Affiliation Scientific Center for Anti-Infective Drug
Country Kazakhstan
Scopus ID 21735405800
Documents 7
Citations 35
h-index 5
Subject Area Drug synergy
Event Global Diseases Research Awards
ORCID 0000-0003-2881-0307

Gulnara Yuldasheva is associated with the Scientific Center for Anti-Infective Drug in Kazakhstan and has contributed to the advancement of research in drug synergy and anti-infective therapeutic studies. Her scholarly work reflects a focused engagement in antimicrobial research, pharmaceutical sciences, and collaborative approaches to disease-related investigations. The academic profile demonstrates measurable research visibility through indexed publications, citations, and international scholarly recognition.[1]

Abstract

The Women Researcher Award recognizes academic and scientific contributions that demonstrate relevance, scholarly consistency, and engagement with emerging challenges in biomedical and pharmaceutical sciences. Gulnara Yuldasheva has contributed to the field of anti-infective drug research with particular attention to drug synergy, antimicrobial investigations, and interdisciplinary pharmaceutical approaches. Her research activities are represented through indexed scientific publications and citation-based academic visibility, indicating active participation in internationally recognized scientific communication.[1][2]

Keywords

  • Drug synergy
  • Anti-infective research
  • Pharmaceutical sciences
  • Biomedical research
  • Women in science
  • Global Diseases Research Awards

Introduction

Research in anti-infective therapeutics continues to play a significant role in addressing global public health challenges related to infectious diseases and antimicrobial resistance. Scientific investigations involving drug synergy provide insights into the combined effects of therapeutic compounds and contribute to the optimization of treatment strategies. Researchers engaged in this domain support evidence-based approaches that may improve clinical outcomes and pharmaceutical innovation.[2]

Gulnara Yuldasheva’s academic profile reflects participation in research initiatives connected with anti-infective drug development and interdisciplinary pharmaceutical studies. Her scholarly contributions demonstrate engagement with research dissemination through indexed databases and internationally accessible scientific literature. Such contributions align with the broader objectives of scientific collaboration and innovation in health-related research environments.[1]

Research Profile

The research profile of Gulnara Yuldasheva is associated with studies in anti-infective pharmacology and drug synergy analysis. Her work has contributed to the understanding of therapeutic interactions and scientific approaches relevant to infectious disease management. Indexed publications and citation metrics indicate continuing scholarly engagement within biomedical and pharmaceutical research communities.[1]

  • Affiliated with the Scientific Center for Anti-Infective Drug.
  • Research specialization includes drug synergy and anti-infective therapeutics.
  • Indexed scientific publications available through Scopus.
  • Recognized through measurable citation impact and academic visibility.
  • Engaged in interdisciplinary biomedical and pharmaceutical studies.

Research Contributions

Research contributions associated with Gulnara Yuldasheva include scientific investigations into anti-infective compounds, synergistic drug interactions, and pharmaceutical research methodologies. Such studies support broader scientific understanding related to therapeutic combinations and their relevance in infectious disease management.[2]

Drug synergy research is important for evaluating combined therapeutic effectiveness, minimizing resistance development, and identifying optimized treatment approaches. Through scholarly publication activity, Yuldasheva has contributed to ongoing scientific discussions in this specialized area of pharmaceutical sciences and biomedical investigation.[3]

Publications

The publication record associated with Gulnara Yuldasheva reflects contributions to scientific literature indexed within internationally recognized academic databases. Her scholarly output demonstrates participation in peer-reviewed communication relevant to anti-infective pharmacology and biomedical research.[1]

  1. Research studies addressing anti-infective therapeutic strategies and drug interaction analysis.
  2. Molecular Modeling of the Anti-HIV Activity Mechanism of Iodine-Containing Drugs Armenicum and FS-1Article link copied! [3]
  3. Iodine-Based Coordination Compounds: A Strategy Toward Antibiotic Potentiation [4]

Research Impact

Research impact may be evaluated through publication indexing, citation activity, and scholarly engagement across scientific platforms. The citation profile associated with Gulnara Yuldasheva demonstrates recognition within academic literature and indicates that her work has contributed to discussions related to pharmaceutical and anti-infective sciences.[1]

The documented h-index and citation metrics reflect measurable academic visibility within the scientific community. Such indicators support the significance of continued research participation and contribution to interdisciplinary biomedical knowledge dissemination.[1]

Award Suitability

The Women Researcher Award within the Global Diseases Research Awards framework recognizes scientific contributions that support research excellence, innovation, and scholarly engagement in health sciences. Gulnara Yuldasheva’s profile demonstrates alignment with these objectives through her involvement in anti-infective drug research, indexed scientific output, and measurable citation impact.[5]

Her academic activities indicate sustained participation in biomedical and pharmaceutical investigations relevant to global health and therapeutic innovation. The combination of publication visibility, research specialization, and international indexing supports the suitability of recognition within a research-oriented academic award context.[1]

Conclusion

Gulnara Yuldasheva has contributed to scientific research associated with anti-infective therapeutics and drug synergy studies through indexed publications and interdisciplinary academic engagement. Her scholarly profile reflects measurable research visibility and participation in pharmaceutical science communication. The academic contributions and citation-based impact presented within this profile demonstrate relevance to contemporary biomedical research and support recognition within the Women Researcher Award category of the Global Diseases Research Awards.[1][5]

References

  1. Elsevier. (n.d.). Scopus author details: Gulnara Yuldasheva, Author ID 21735405800. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=21735405800
  2. World Health Organization. (2023). Antimicrobial resistance and anti-infective therapeutic research.
    https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance
  3. Yuldasheva, G. A., Argirova, R., & Ilin, A. I. (2023). Molecular modeling of the anti-HIV activity mechanism of iodine-containing drugs Armenicum and FS-1. ACS Omega, 8(9), 8617–8624
    https://doi.org/10.1021/acsomega.2c07720

  4. Shepilov, D., Askarova, D., Seisembekova, A., Turganbay, S., Jumagaziyeva, A., Bukeyeva, T., Yuldasheva, G., Temir, N., Ivanova, L. N., Zubenko, N., & Kenesheva, S. (2026). Iodine-based coordination compounds: A strategy toward antibiotic potentiation. International Journal of Molecular Sciences, 27(10), 4292.
    https://doi.org/10.3390/ijms27104292

  5. Global Diseases Research Awards. (n.d.). Women Researcher Award recognition and event information.
    https://globaldiseases.org/

Prof. Dr. Zeynep Koloren | Molecular Pharmacology | Women Researcher Award

Published on by Global Diseases Research

Prof. Dr. Zeynep Koloren | Molecular Pharmacology | Women Researcher Award

Ordu University | Turkey

Prof. Dr. Zeynep Kolören is a distinguished academic affiliated with Ordu Üniversitesi, specializing in parasitology, molecular biology, and antimicrobial research with a strong focus on protozoan pathogens such as Acanthamoeba castellanii. With a robust research portfolio comprising 41 peer-reviewed publications and 352 citations, and an h-index of 12, she has demonstrated consistent scholarly impact and scientific productivity. Her work integrates natural product research, gene expression analysis, and nanotechnology-based therapeutic approaches, contributing to advancements in infectious disease control. Prof. Kolören has actively collaborated with a network of 47 co-authors, reflecting her engagement in interdisciplinary and international research efforts. Her studies on plant-derived compounds and novel antimicrobial agents highlight a commitment to developing sustainable and effective solutions for global health challenges, reinforcing her contribution to both scientific knowledge and societal well-being.

Citation Metrics (Scopus)
352
290
150
50
0

Citations

352

Documents

41

h-index

12

Citations

Documents

h-index

View Scopus Profile
   View Google Scholar Profile

Top 5 Featured Publications

 

Peter Asaga Mac | Infectious diseases | Best Researcher Award

Published on by Global Diseases Research

Dr. Peter Asaga Mac | Infectious diseases | Best Researcher Award 

Senior clinical research fellow | University Hospital Freiburg | Germany

Dr. Peter Asaga Mac is a dedicated researcher at Universitätsklinikum Freiburg, Freiburg im Breisgau, Germany, specializing in infectious and zoonotic diseases. His scientific work focuses on understanding the epidemiology, immune response, and transmission dynamics of emerging viral infections, particularly mosquito-borne diseases such as Chikungunya and Dengue. Through a combination of field-based studies, serological analyses, and molecular surveillance, Dr. Mac investigates how co-circulating arboviruses interact within populations and contribute to public health challenges in endemic regions, especially in Africa. His notable publication, “An Undetected Expansion, Spread, and Burden of Chikungunya and Dengue Cocirculating Antibodies in Nigeria” (Zoonotic Diseases, 2024), provides valuable insight into the unnoticed expansion of these viruses and their long-term implications for disease control strategies. Dr. Mac’s research is characterized by its translational value—bridging scientific discovery with actionable health interventions to improve epidemic preparedness and response. His collaborations with international scientists strengthen global efforts to monitor zoonotic threats and develop more resilient surveillance systems. Despite being an early-career researcher, his contributions are gaining recognition within the academic community. With 3 publications, 14 citations  and an h-index of 2, Dr. Mac’s growing academic footprint reflects his potential to make lasting contributions to infectious disease research, particularly in the areas of viral immunology, epidemiological modeling, and global health resilience. His commitment to evidence-based solutions continues to shape a better understanding of emerging diseases and their impact on human health worldwide.

Profiles: Scopus | ORCID | Google Scholar

Featured Publications

1. Chackalackal, D. J., Al-Aghbari, A. A. A., Jang, S. Y., Ramirez, T. R., Vincent, J., Joshi, A., et al. (2021). The Covid-19 pandemic in low- and middle-income countries: Who carries the burden? Review of mass media and publications from six countries. Pathogens and Global Health, 115(3), 178–187.
Cited by: 49

2. Mac, P. A., Suleiman, A. C., & Airiohuodion, P. E. (2019). High prevalence of hepatitis B virus infection among pregnant women attending antenatal care in Central Nigeria. Journal of Infectious Diseases and Epidemiology, 5(1), 068.
Cited by: 34

3. Mac, P. A., Asheadzi, H. F., Gideon, A., Thaker, P., & Airiohuodion, P. (2019). Prevalence of Plasmodium falciparum among Nigerians in Abuja and Central States: A comparative analysis of sensitivity and specificity using rapid diagnostic test and microscopy. International Journal of Tropical Diseases, 1, 014.
Cited by: 22

4. Mac, P. A., Kroeger, A., & Airiohuodion, P. E. (2019). Needs assessment of emergency medical and rescue services in Abuja/Nigeria and environs. BMC Emergency Medicine, 19(78), 8.
Cited by: 21

5. Mac, P. A., Airiohuodion, P. E., Yako, A. B., et al. (2022). The seroprevalence and hidden burden of chikungunya endemicity and malaria mono- and coinfection in Nigeria. International Journal of Environmental Research and Public Health, 19(15), 8896.
Cited by: 19

Amos Kipkorir Langat | Infectious Disease | Best Researcher Award

Published on by Global Diseases Research

Assist. Prof. Dr. Amos Kipkorir Langat | Infectious Disease | Best Researcher Award 

Senior Research Fellow | Jomo Kenyatta University of Agriculture and Techno | Kenya

Dr. Amos Kipkorir Langat, Ph.D., is a highly accomplished statistician, academic, and economist with expertise in Bayesian analysis, machine learning, spatial statistics, and public health modeling. He earned his Ph.D. in Mathematics (Statistics) from the Pan African University Institute for Basic Sciences, Technology and Innovation, his MSc. in Applied Statistics from Jomo Kenyatta University of Agriculture and Technology (JKUAT), and his BSc. in Economics and Mathematics from Kabarak University. Currently, he serves as a Lecturer at JKUAT and Senior Economist at the County Government of Bomet, with previous teaching roles at Maasai Mara and Kabarak Universities. His research spans statistical modeling of infectious diseases, HIV risk factors, maternal health, survival and time series analysis, and measurement error models. He has supervised MSc. and Ph.D. students across Africa, authored over 30 peer-reviewed publications, and contributed to journals such as Scientific African, Asian Journal of Probability and Statistics, and Annals of Medicine & Surgery. Dr. Langat has secured prestigious awards including the AU Ph.D. Scholarship and SICSS research funding, and he actively contributes as a reviewer and conference organizer. His technical expertise includes proficiency in R, Python, STATA, SAS, SPSS, WinBUGS/OpenBUGS, and advanced econometric tools. A member of the Royal Statistical Society, ISCB, IBS, and the Kenya National Statistical Society, he also demonstrates a strong commitment to community service through educational leadership roles. Dr. Langat exemplifies a dedicated scholar, mentor, and researcher advancing applied statistics in public health and beyond

Profile: Google Scholar | Scopus | Orcid

Featured Publications

1. Langat, A., Orwa, G., & Koima, J. (2017). Cancer cases in Kenya; forecasting incidents using Box & Jenkins ARIMA model. Biomedical Statistics and Informatics, 2(2), 37–48. Cited by: 21

2. Benki-Nugent, S. F., Martopullo, I., Laboso, T., Tamasha, N., Wamalwa, D. C., … [and others]. (2019). High plasma soluble CD163 during infancy is a marker for neurocognitive outcomes in early-treated HIV-infected children. JAIDS Journal of Acquired Immune Deficiency Syndromes, 81(1), 102–109. Cited by: 14

3. Mutinda, J. K., & Langat, A. K. (2024). Stock price prediction using combined GARCH-AI models. Scientific African, 26, e02374. Cited by: 10

4. Mutinda, J. K., & Langat, A. K. (2024). Modeling the impact of air pollution and meteorological variables on COVID-19 transmission in Western Cape, South Africa. International Journal of Mathematics and Mathematical Sciences, 2024(1), 1591016. Cited by: 5

5. Mutinda, J. K., & Langat, A. K. (2024). Capital asset pricing model: A renewed application on S&P 500 index. Asian Journal of Economics, Business and Accounting, 24(6), 226–239. Cited by: 4